[ 메디채널 김갑성 기자 ] The published study results are from the ENLIGHT UC study (ES101002), a multicenter, randomized, double-blind and placebo-controlled Phase III trial of etrasimod conducted across Asia. The study included a 12-week induction phase followed by a 40-week maintenance phase and represents the largest pivotal Phase III study to date in Asian patients with moderately to severely active ulcerative colitis. The study results showed that, during both the 12-week induction phase and the 40-week maintenance phase, etrasimod demonstrated statistically significant and clinically meaningf
RIO DE JANEIRO, Oct. 9, 2025 -- Anbio Biotechnology participated in the 50th World Small Animal Veterinary Association Congress (WSAVA 2025), an international gathering that brought together veterinarians, researchers, and industry representatives from more than 100 countries. The event provided a platform for Anbio to present its veterinary diagnostic portfolio and exchange views with partners across global markets. At WSAVA 2025, Anbio displayed five product lines: Fluorescence Immunoassay (FIA) Dry Chemistry Molecular Diagnostics Colloidal Gold Rapid Tests Dry Chem
SINGAPORE, Oct. 9, 2025 -- Neopharma Technologies Ltd ("Neopharma"), a digital health company pioneering AI-driven Digital Drug and Impairment Testing, today announced the appointment of Mr. Joo Seng Wong to its Advisory Board. Mr. Wong will play a key role in strengthening Neopharma's institutional strategy, execution frameworks, and global commercialization roadmap as the company advances toward its planned NASDAQ listing. Institutional Credibility and Strategic Depth Mr. Wong is one of Singapore's most accomplished financial and technology lead
Facility marks EDAN's 30th anniversary and kickstarts global supply chain ecosystem SAN DIEGO, Oct. 9, 2025 -- Edan Instruments, Inc. (300206.SZ), a global leader in medical device innovation, announced the official opening of its new U.S. manufacturing hub in San Diego, California, on September 30, 2025. Building on more than 15 years of local presence through its San Diego office, the milestone marks EDAN Diagnostics, Inc.'s first U.S.-based production site and strengthens the company's presence in the region, enhancing its ability to support healthcare providers with advance
도쿄, 2025년 10월 8일 -- 세계명상연맹(World Meditation League•WML)과 올히어(All Here)가 일본 도쿄 핫포엔(Happo-en) 정원에서 일본 최초의 도쿄 정량화 명상 챌린지(Tokyo Quantified Meditation Challenge)를 선보이며 명상이 새로운 시대에 접어들었다. 이와 같은 전례 없는 행사는 명상을 개인의 내면 성찰에서 벗어나 신경과학을 통해 측정과 관찰이 가능한 경쟁적인 분야로 변화시켰다. 행사에서 참가자의 두뇌 활동, 집중도, 자기 인식, 내면의 고요가 정량화된 데이터로 화면에 시각적으로 표시되자 관객들은 처음으로 명상의 효과를 실시간으로 목격했다. 기술 × 건축 × 자연 — 쿠마 겐고와 올히어가 개발한 명상 캡슐 공개 오후 행사는 세계적으로 유명한 건축가 쿠마 겐고(Kengo Kuma)의 발표로 시작됐다. 그는 올히어가 개발한 몰입형 명상 XR 플랫폼 젠부 코코(Zenbu Koko)를 공개했다. 쿠마 겐고는 "나는 오래전부터 건축, 공허함, 자연을 매끄럽게 연결하고 싶었다
SEOUL, South Korea, Oct. 9, 2025 -- The World Federation of Neurology (WFN) and the Korean Neurological Association (KNA) will host the XXVII World Congress of Neurology (WCN) in Seoul, South Korea, from Oct. 12-15, 2025. WCN is a major, biennial conference that brings together world-class neurologists, experts, researchers, and clinicians from across the globe to showcase the latest advances in brain science, neurology, and patient care. The congress theme, "The Soul of Neurological Innovation," is exemplified through an elite Scientific Program featuring some of the
SALT LAKE CITY, Oct. 8, 2025 -- TCI Biotech, a global biotechnology leader in health and wellness, today announced the release of its 2024 Environmental, Social, and Governance (ESG) Report, marking a milestone year of brand renewal, international sustainability recognition, and measurable ESG results. Alongside the report, TCI announced top honors at the 2025 Green World Awards and the International CSR Excellence Awards, reaffirming its position as a global sustainability innovator serving 67 countries worldwide. Brand Renewal and Global Vision In 2025, TCI Biotech intr
BARCELONA, Spain, Oct. 8, 2025 -- During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM 2025), C-Ray Therapeutics (Shanghai) Co., Ltd. ("C-Ray Shanghai"), a company dedicated to the development of innovative targeted radiopharmaceuticals, announced promising new clinical results for its lead program 225Ac-PSMA-CY313 in the treatment of metastatic castration-resistant prostate cancer (mCRPC). These data, highlighted in two Top Rated Oral Presentations, provide early clinical evidence of the therapy's significant potential and favorable s
CHENNAI, India, Oct. 8, 2025 -- India's No:1 Ranked Institute, the Indian Institute of Technology Madras, and Danish researchers have shown how interactions between genetic variants can act like 'switches' to unlock hidden cellular pathways. The findings of this research, undertaken jointly with the Technical University of Denmark, were published in a research paper in the prestigious, internationally-renowned Nature Communications journal (DOI: 10.1038/s41467-025-63306-4), an open-access journal also published by Springer Nature. In this study, the researchers, using sy
The Fund for Congolese Women named 2025 .ORG of the Year, selected from nearly 3,000 applicants from more than 120 countries WASHINGTON, Oct. 8, 2025 -- Public Interest Registry (PIR), the people behind the .ORG domain, announced the winners of the 2025 ORG Impact Awards, an annual celebration recognizing and rewarding outstanding mission-driven individuals and organizations from around the world for their positive contributions to society. The seven winners — selected from nearly 3,000 applicants from more than 120 countries — were announced live at the awards ceremony, which